Skip to main content
. Author manuscript; available in PMC: 2009 Apr 7.
Published in final edited form as: Int J Cancer. 2009 Feb 1;124(3):664–669. doi: 10.1002/ijc.24007

Figure 4.

Figure 4

Serum endoglin levels in patients A) without prostate cancer (Normal, n=20) and with prostate cancer (Cancer, n=69), and B) with organ-confined prostate cancer (pT2, n=30), and with non-organ confined prostate cancer (pT3+, n=39).